18F-FDG PET/CT contributes to diagnostics and therapy monitoring of radiation-induced angiosarcoma
Cucchi, F.; Bülow, J.; Simonsen, L.; Nedergaard, L.; Haarmark, C.; Asmar, A.
Ugeskrift for Laeger 179(1)
2017
ISSN/ISBN: 0041-5782 PMID: 28074770 Document Number: 692468
Angiosarcomas are rare, aggressive malignant mesenchymal tumours with a poor prognosis. Radiation therapy is an independent risk factor for the development of secondary angiosarcoma. The onset of angiosarcoma may resemble benign lesions, leading to delayed diagnosis. It has been suggested that 18F-fluorodeoxyglucose (FDG) PET/CT scan may be useful in the early diagnosis in differentiating angiosarcoma from benign lesions and in therapy monitoring. We report the utility of 18F-FDG PET/CT scan in the diagnosis and follow-up of radiation-induced angiosarcoma in a patient previously treated for uterine cancer.